title: Improvement in QTc prolongation induced by zotepine following a switch to perospirone.
authors.forename: Yutaro
authors.initials: Y
authors.lastname: Suzuki
authors.forename: Junzo
authors.initials: J
authors.lastname: Watanabe
authors.forename: Takuro
authors.initials: T
authors.lastname: Sugai
authors.forename: Naoki
authors.initials: N
authors.lastname: Fukui
authors.forename: Shin
authors.initials: S
authors.lastname: Ono
authors.forename: Nobuto
authors.initials: N
authors.lastname: Tsuneyama
authors.forename: Mami
authors.initials: M
authors.lastname: Saito
authors.forename: Toshiyuki
authors.initials: T
authors.lastname: Someya
mesh_terms: D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D003988:Dibenzothiepins / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D004562:Electrocardiography / Q000187:drug effects; D005260:Female; D006220:Haloperidol / Q000627:therapeutic use; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D054833:Isoindoles / Q000008:administration & dosage / Q000627:therapeutic use*; D008133:Long QT Syndrome / Q000139:chemically induced*; D008875:Middle Aged; D012559:Schizophrenia / Q000188:drug therapy; D013844:Thiazoles / Q000008:administration & dosage / Q000627:therapeutic use*; D014883:Water-Electrolyte Imbalance / Q000097:blood / Q000139:chemically induced
chemical_list: D014150:Antipsychotic Agents; D003988:Dibenzothiepins; D054833:Isoindoles; D013844:Thiazoles; D006220:Haloperidol; C065533:perospirone; C022172:zotepine